Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An investigator sponsored trial of Plasmid DNA based cancer vaccine in the patients with glioblastoma

Next Previous
X
Search
Trial Profile

An investigator sponsored trial of Plasmid DNA based cancer vaccine in the patients with glioblastoma

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2019

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cancer DNA vaccine (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions

    • Most Recent Events

    • 05 Feb 2019 New trial record
    • 29 Jan 2019 According to a Genetic Immunity media release, this trial will be conducted in Moscow, Russia, at the European Medical Center.
    • 29 Jan 2019 According to a Genetic Immunity media release, Professor Alexey Krivoshapkin, a world-renowned neurosurgeon, will be the principal investigator of this trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top